Related Experiment Video
Updated: Jun 19, 2026

A Semi-automated Approach to Preparing Antibody Cocktails for Immunophenotypic Analysis of Human Peripheral Blood
Published on: February 8, 2016
[Evaluation of whole blood immunoreactivity]
I A Seledtsova1, T Ya Lyubavskaya1, A A Pyshenko1
1Petrovsky National Research Center of Surgery, Moscow, Russia.
This study shows lipopolysaccharide (LPS) and Concanavalin A (Con A) stimulate different immune responses in whole blood. The findings offer insights into assessing blood immunoreactivity for clinical applications.
Area of Science:
- Immunology
- Cellular Biology
Context:
- Assessing cellular immunoreactivity is crucial for understanding immune responses.
- Whole blood assays provide a model for studying immune cell activation.
- Cytokine profiles reflect specific immune cell stimulation.
Purpose:
- To investigate the differential effects of lipopolysaccharide (LPS) and Concanavalin A (Con A) on human whole blood cytokine production.
- To evaluate the impact of heparin on immune responses stimulated by LPS and Con A.
- To explore the utility of this assay for assessing innate and adaptive blood immunoreactivity.
Summary:
- Lipopolysaccharide (LPS) preferentially stimulated the release of tumor necrosis factor-alfa (TNF-α), interleukin-6 (IL-6), IL-10, and vascular endothelial growth factor (VEGF).
- Concanavalin A (Con A) significantly enhanced the secretion of interferon-gamma (IFN-γ) and IL-2.
- Heparin addition showed a minor decrease in IL-2 and VEGF secretion, without affecting other measured cytokines.
Impact:
- This assay can differentiate immune responses to various stimuli in whole blood.
- The findings support the use of this method for objective immunologic monitoring.
- Potential applications include the preparation of blood components in surgical practice.
More Related Videos
18:48In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024